Enhancement by vasopressin of adrenergic responses in human mesenteric arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 3 41-3, 1997, Pages

  Medina, Pascual ^a   Noguera, Inmaculada ^a   Aldasoro, Martín ^a   Vila, José M ^a   Flor, Blas ^a   Lluch, Salvador ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

electric stimulation; human arteries; norepinephrine

Indexed keywords

ARGIPRESSIN[1 (3,3 CYCLOPENTAMETHYLENE 3 MERCAPTOPROPIONIC ACID) 2 (O METHYLTYROSINE)]; NIFEDIPINE; NORADRENALIN; POTASSIUM CHLORIDE; VASOPRESSIN; VASOPRESSIN V1 RECEPTOR;

ADRENERGIC STIMULATION; ADULT; AGED; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL INNERVATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MESENTERIC ARTERY; PRIORITY JOURNAL; VASOPRESSIN BLOOD LEVEL;

EID: 33751290235     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.3.h1087     Document Type: Article

References (30)

1. Aylward, P. E., J. S. Floras, W. N. Leimbach, and F. M. Abboud. Effects of vasopressin on the circulation and its baroreflex control in healthy men. Circulation 73: 1145-1154, 1986.
2. Bartelstone, H. J., and P. A. Nasmyth. Vasopressin potentiation of catecholamine actions in dog, rat, cat and rat aortic strip. Am. J. Physiol. 208: 754-762, 1965.
3. Creager, M. A., D. P. Faxon, S. S. Cutler, O. Kohlmann, T. J. Ryan, and H. Gavras. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with renin-angiotensin system and the sympathetic nervous system. J. Am. Coll. Cardiol. 7: 758-765, 1986.
4. Duckworth, J. W., G. C. Cuellman, C. L. Walters, and J. A. Bevan. Aminergic histofluorescence and contractile responses to transmural electrical field stimulation and norepinephrine of human middle cerebral arteries obtained promptly after death. Circ. Res. 65: 316-324, 1989.
5. Garner, W. L., P. D. Thomson, N. P. Moore, J. L. Rodriguez, and D. J. J. Smith. Effect of triglycyl-lysine-vasopressin on skin blood flow and blood loss during wound excision in patients with burns. J. Burn Care Rehabil. 14: 258-260, 1993.
6. G-nitro-L-arginine methyl ester and vasopressin in endotoxin-treated pithed rats. Eur. J. Pharmacol. 224: 63-69, 1992.
7. Harada, S., T. Imaizumi, M. Momohara, H. Masaki, S. I. Ando, and A. Takeshita. Arginine vasopressin attenuates phenylephrine-induced forearm vasoconstriction in men. Clin. Sci. Lond. 81: 733-737, 1991.
8. Hirsch, A. T., V. J. Dzau, J. A. Majzoub, and M. A. Creager. Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor. J. Clin. Invest. 84: 418-426, 1989.
9. Ishikawa, S., J. P. Goldberg, D. M. Schrier, G. A. Aisenbrey, and R. W. Schrier. Interrelationship between subpressor effects of vasopressin and other vasoactive hormones in the rat. Miner. Electrolyte Metab. 10: 184-189, 1984.
10. Karmazyn, M., M. S. Manky, and D. F. Horrobin. Changes of vascular reactivity induced by low vasopressin concentrations: interactions with cortisol and lithium and possible involvement of prostaglandins. Endocrinology 102: 1230-1236, 1978.
11. Liard, J. F., and J. C. Spadone. Hemodynamic effects of antagonists of the vasoconstrictor action of vasopressin in conscious dogs. J. Cardiovasc. Pharmacol. 6: 713-719, 1984.
12. Liu, S. F., D. E. Crawley, T. W. Evans, and P. J. Barnes. Endogenous nitric oxide modulates adrenergic neural vasoconstriction in guinea-pig pulmonary artery. Br. J. Pharmacol. 104: 565-569, 1991.
13. Lluch, S., M. V. Conde, G. Diéguez, A. L. López de Pablo, M. C. González, C. Estrada, and B. Gómez. Evidence for the direct effect of vasopressin on human and goat cerebral arteries. J. Pharmacol. Exp. Ther. 228: 749-755, 1984.
14. Martín de Aguilera, E., J. M. Vila, A. Irurzun, M. C. Martínez, M. A. Martínez Cuesta, and S. Lluch. Endothelium-independent contractions of human cerebral arteries in response to vasopressin. Stroke 21: 1689-1693, 1990.
15. Martínez, M. C., M. Aldasoro, J. M. Vila, P. Medina, and S. Lluch. Responses to vasopressin and desmopressin of human cerebral arteries. J. Pharmacol. Exp. Ther. 270: 622-627, 1994.
16. Martínez, M. C., J. M. Vila, M. Aldasoro, P. Medina, B. Flor, and S. Lluch. Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin. Br. J. Pharmacol. 113: 419-424, 1994.
17. Melin, B., P. J. Eclache, G. Geelen, G. Annat, A. M. Allevard, E. Jarsaillon, A. Zebidi, J. J. Legros, and C. I. Gharib. Plasma AVP, neurophysin, renin activity, and aldosterone during submaximal exercise performed until exhaustion in trained and untrained men. Eur. J. Appl. Physiol. Occup. Physiol. 44: 141-151, 1980.
18. Michell, R. M., C. J. Kirk, and M. M. Billah. Hormonal stimulation of phosphatidylinositol breakdown, with particular reference to the hepatic effects of vasopressin. Biochem. Soc. Trans. 7: 861-865, 1979.
19. Nicod, P., B. Waeber, J. P. Bussien, J. J. Goy, G. Turini, J. Nussberger, K. G. Hofbauer, and H. R. Brunner. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure. Am. J. Cardiol. 55: 1043-1047, 1985.
20. Ohlstein, E. H., and B. A. Berkowitz. Human vascular vasopressin receptors: analysis with selective vasopressin receptor antagonists. J. Pharmacol. Exp. Ther. 239: 737-741, 1986.
21. Osborn, J. W. J., J. F. Liard, and A. W. J. Cowley. Effect of AVP on pressor responses to peripheral sympathetic stimulation in the rat. Am. J. Physiol. 252 (Heart Circ. Physiol. 21): H675-H680, 1987.
22. Panés, J., J. M. Piqué, J. M. Bordas, J. Llach, J. Bosch, J. Terés, and J. Rodés. Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy. Hepatology 19: 55-60, 1994.
23. Penit, J., M. Faure, and S. Jard. Vasopressin and angiotensin II receptors in rat aortic muscle cells in culture. Am. J. Physiol. 244 (Endocrinol. Metab. 7): E72-E82, 1983.
24. Share, L. Role of vasopressin in cardiovascular regulation. Physiol. Rev. 68: 1248-1284, 1988.
25. Sorenson, P. S., and M. Hammer. Vasopressin in plasma and ventricular cerebrospinal fluid during dehydration, postural changes, and nausea. Am. J. Physiol. 248 (Regulatory Integrative Comp. Physiol. 17): R78-R83, 1985.
26. Suzuki, S., A. Takeshita, T. Imaizumi, Y. Hirooka, M. Yoshida, S. Ando, and M. Nakamura. Biphasic forearm vascular responses to intraarterial arginine vasopressin. J. Clin. Invest. 84: 427-434, 1989.
27. Suzuki, S., A. Takeshita, T. Imaizumi, Y. Hirooka, M. Yoshida, S. Ando, and M. Nakamura. Central nervous system mechanisms involved in inhibition of renal sympathetic nerve activity induced by arginine vasopressin. Circ. Res. 65: 1390-1399, 1989.
28. Tagawa, T., T. Imaizumi, M. Shiramoto, T. Endo, K. Hironaga, and A. Takeshita. V2 receptor-mediated vasodilation in healthy humans. J. Cardiovasc. Pharmacol. 25: 387-392, 1995.
29. Thibonnier, M., A. L. Bayer, C. L. Laethem, D. R. Koop, and M. S. Simonson. Role of eicosanoids in vasopressin-induced calcium mobilization in A7r5 vascular smooth muscle cells. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E108-E114, 1993.
30. White, R. P., and J. T. Robertson. Pharmacodynamic evaluation of human cerebral arteries in the genesis of vasospasm. Neurosurgery 21: 523-531, 1987.